[AVTE] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
29-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -15.34%
YoY- -82.68%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 136 0 0 0 -
PBT -20,357 -14,997 -8,220 -3,666 77.08%
Tax 56 25 3 -647 -
NP -20,413 -15,022 -8,223 -3,666 77.24%
Tax Rate - - - - -
Total Cost 20,549 15,022 8,223 3,666 77.63%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -15,009.56 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.74 -0.61 -0.34 -15.08 -63.38%
EPS Diluted -0.74 -0.61 -0.34 -15.08 -63.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.